185 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Migchels C, Zerrouk A, Crunelle CL, Matthys F, Gremeaux L, Fernandez K, Antoine J, van den Brink W, Vanderplasschen W. Patient Reported Outcome and Experience Measures (PROMs and PREMs) in substance use disorder treatment services: A scoping review. Drug and Alcohol Dependence. 253: 111017. PMID 37995391 DOI: 10.1016/j.drugalcdep.2023.111017  0.578
2022 Brynte C, Aeschlimann M, Barta C, Begeman AHA, Bäcker A, Crunelle CL, Daigre C, De Fuentes-Merillas L, Demetrovics Z, Dom G, López LG, Icick R, Johnson B, Joostens P, Kapitány-Fövény M, ... ... van den Brink W, et al. The clinical course of comorbid substance use disorder and attention deficit/hyperactivity disorder: protocol and clinical characteristics of the INCAS study. Bmc Psychiatry. 22: 625. PMID 36151539 DOI: 10.1186/s12888-022-04259-6  0.598
2021 Özgen H, Spijkerman R, Noack M, Holtmann M, Schellekens ASA, van de Glind G, Banaschewski T, Barta C, Begeman A, Casas M, Crunelle CL, Daigre Blanco C, Dalsgaard S, Demetrovics Z, den Boer J, ... ... van den Brink W, et al. [International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder]. Zeitschrift Fur Kinder- Und Jugendpsychiatrie Und Psychotherapie. PMID 34397296 DOI: 10.1024/1422-4917/a000828  0.596
2021 Pape L, van Lith K, Veltman D, Cohn M, Marhe R, van den Brink W, Doreleijers T, Popma A. Effect of Methylphenidate on Resting-State Connectivity in Adolescents With a Disruptive Behavior Disorder: A Double-Blind Randomized Placebo-Controlled fMRI Study. Frontiers in Psychiatry. 12: 662652. PMID 34220576 DOI: 10.3389/fpsyt.2021.662652  0.586
2021 Marees AT, Smit DJA, Abdellaoui A, Nivard MG, van den Brink W, Denys D, Galama TJ, Verweij KJH, Derks EM. Genetic correlates of socio-economic status influence the pattern of shared heritability across mental health traits. Nature Human Behaviour. PMID 33686200 DOI: 10.1038/s41562-021-01053-4  0.523
2021 Abdellaoui A, Smit DJA, van den Brink W, Denys D, Verweij KJH. Genomic relationships across psychiatric disorders including substance use disorders. Drug and Alcohol Dependence. 220: 108535. PMID 33524898 DOI: 10.1016/j.drugalcdep.2021.108535  0.562
2020 Kapitány-Fövény M, Barta C, Crunelle CL, van den Brink W, Moggi F, Konstenius M, Franck J, Levin FR, van de Glind G, Coetzee C, Luderer M, Schellekens A, Matthys F, Demetrovics Z. [Recommendations for the screening, diagnosis and treatment of patients with comorbid attention deficit hyperactivity- and substance use disorder]. Psychiatria Hungarica : a Magyar Pszichiatriai Tarsasag Tudomanyos Folyoirata. 35: 435-447. PMID 33263293  0.6
2020 Özgen H, Spijkerman R, Noack M, Holtmann M, Schellekens ASA, van den Glind G, Banaschewski T, Barta C, Begeman A, Casas M, Crunelle CL, Daigre Blanco C, Dalsgaard S, Demetrovics Z, den Boer J, ... ... van den Brink W, et al. International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder. European Addiction Research. 1-10. PMID 32634814 DOI: 10.1159/000508385  0.593
2020 Schellekens AFA, van den Brink W, Kiefer F, Goudriaan AE. Often Overlooked and Ignored, but Do Not Underestimate Its Relevance: ADHD in Addiction - Addiction in ADHD. European Addiction Research. 1-4. PMID 32615559 DOI: 10.1159/000509267  0.637
2020 Van de Glind G, Brynte C, Skutle A, Kaye S, Konstenius M, Levin F, Mathys F, Demetrovics Z, Moggi F, Ramos-Quiroga JA, Schellekens A, Crunelle C, Dom G, van den Brink W, Franck J. The International Collaboration on ADHD and Substance Abuse (ICASA): Mission, Results, and Future Activities. European Addiction Research. 1-6. PMID 32599579 DOI: 10.1159/000508870  0.596
2020 Palma-Álvarez RF, Barta C, Carpentier PJ, Carruthers S, Crunelle CL, Demetrovics Z, Dom G, Faraone SV, Franck J, Johnson B, Kapitány-Fövény M, Kaye S, Konstenius M, Matthys F, Moggi F, ... ... van den Brink W, et al. Validity of the ADHD module of the Mini International Neuropsychiatric Interview PLUS for screening of adult ADHD in treatment seeking substance use disorder patients: ADHD screening with MINI-Plus. Revista De Psiquiatria Y Salud Mental. PMID 32561156 DOI: 10.1016/J.Rpsm.2020.04.013  0.585
2019 van Emmerik-van Oortmerssen K, Blankers M, Vedel E, Kramer F, Goudriaan AE, van den Brink W, Schoevers RA. Prediction of drop-out and outcome in integrated cognitive behavioral therapy for ADHD and SUD: Results from a randomized clinical trial. Addictive Behaviors. 103: 106228. PMID 31838443 DOI: 10.1016/J.Addbeh.2019.106228  0.663
2019 Jansen JM, van den Heuvel OA, van der Werf YD, de Wit SJ, Veltman DJ, van den Brink W, Goudriaan AE. The Effect of High-Frequency Repetitive Transcranial Magnetic Stimulation on Emotion Processing, Reappraisal, and Craving in Alcohol Use Disorder Patients and Healthy Controls: A Functional Magnetic Resonance Imaging Study. Frontiers in Psychiatry. 10: 272. PMID 31133889 DOI: 10.3389/Fpsyt.2019.00272  0.801
2019 Jansen JM, van den Heuvel OA, van der Werf YD, de Wit SJ, Veltman DJ, van den Brink W, Goudriaan AE. Emotion Processing, Reappraisal, and Craving in Alcohol Dependence: A Functional Magnetic Resonance Imaging Study. Frontiers in Psychiatry. 10: 227. PMID 31057439 DOI: 10.3389/Fpsyt.2019.00227  0.79
2019 Luigjes J, Lorenzetti V, de Haan S, Youssef GJ, Murawski C, Sjoerds Z, van den Brink W, Denys D, Fontenelle LF, Yücel M. Defining Compulsive Behavior. Neuropsychology Review. 29: 4-13. PMID 31016439 DOI: 10.1007/S11065-019-09404-9  0.775
2019 van der Burg D, Crunelle CL, Matthys F, van den Brink W. Diagnosis and treatment of patients with comorbid substance use disorder and adult attention-deficit and hyperactivity disorder: a review of recent publications. Current Opinion in Psychiatry. PMID 31008730 DOI: 10.1097/YCO.0000000000000513  0.603
2019 Marees AT, Smit DJA, Ong JS, MacGregor S, An J, Denys D, Vorspan F, van den Brink W, Derks EM. Potential influence of socioeconomic status on genetic correlations between alcohol consumption measures and mental health. Psychological Medicine. 1-15. PMID 30874500 DOI: 10.1017/S0033291719000357  0.582
2018 van Lith K, Veltman DJ, Cohn MD, Pape LE, van den Akker-Nijdam ME, van Loon AWG, Bet P, van Wingen GA, van den Brink W, Doreleijers T, Popma A. Effects of Methylphenidate During Fear Learning in Antisocial Adolescents: A Randomized Controlled fMRI Trial. Journal of the American Academy of Child and Adolescent Psychiatry. 57: 934-943. PMID 30522739 DOI: 10.1016/J.Jaac.2018.06.026  0.572
2018 de Waal MM, Dekker JJM, Kikkert MJ, Christ C, Chmielewska J, Staats MWM, van den Brink W, Goudriaan AE. Self-wise, Other-wise, Streetwise (SOS) training, an intervention to prevent victimization in dual diagnosis patients: results from a randomized clinical trial. Addiction (Abingdon, England). PMID 30461111 DOI: 10.1111/add.14500  0.635
2018 Yücel M, Oldenhof E, Ahmed S, Belin D, Billieux J, Bowden-Jones H, Carter A, Chamberlain SR, Clark L, Connor J, Daglish M, Dom G, Dannon P, Duka T, Fernandez-Serrano MJ, ... ... van den Brink W, et al. A transdiagnostic dimensional approach towards a neuropsychological assessment for addiction: an international Delphi consensus study. Addiction (Abingdon, England). PMID 30133930 DOI: 10.1111/Add.14424  0.772
2018 Marees AT, Hammerschlag AR, Bastarache L, de Kluiver H, Vorspan F, van den Brink W, Smit DJ, Denys D, Gamazon ER, Li-Gao R, Breetvelt EJ, de Groot MCH, Galesloot TE, Vermeulen SH, Poppelaars JL, et al. Exploring the role of low-frequency and rare exonic variants in alcohol and tobacco use. Drug and Alcohol Dependence. 188: 94-101. PMID 29758381 DOI: 10.1016/J.Drugalcdep.2018.03.026  0.571
2018 Kaag AM, Schulte MHJ, Jansen JM, van Wingen G, Homberg J, van den Brink W, Wiers RW, Schmaal L, Goudriaan AE, Reneman L. The relation between gray matter volume and the use of alcohol, tobacco, cocaine and cannabis in male polysubstance users. Drug and Alcohol Dependence. 187: 186-194. PMID 29679913 DOI: 10.1016/J.Drugalcdep.2018.03.010  0.788
2018 Schulte MHJ, Wiers RW, Boendermaker WJ, Goudriaan AE, van den Brink W, van Deursen DS, Friese M, Brede E, Waters AJ. Reprint of The effect of N-acetylcysteine and working memory training on cocaine use, craving and inhibition in regular cocaine users: correspondence of lab assessments and Ecological Momentary Assessment. Addictive Behaviors. PMID 29661657 DOI: 10.1016/j.addbeh.2018.03.023  0.673
2018 Kaag AM, Reneman L, Homberg J, van den Brink W, van Wingen GA. Enhanced Amygdala-Striatal Functional Connectivity during the Processing of Cocaine Cues in Male Cocaine Users with a History of Childhood Trauma. Frontiers in Psychiatry. 9: 70. PMID 29593581 DOI: 10.3389/Fpsyt.2018.00070  0.768
2018 Crunelle CL, van den Brink W, Moggi F, Konstenius M, Franck J, Levin FR, van de Glind G, Demetrovics Z, Coetzee C, Luderer M, Schellekens A, Matthys F. International Consensus Statement on Screening, Diagnosis and Treatment of Substance Use Disorder Patients with Comorbid Attention Deficit/Hyperactivity Disorder. European Addiction Research. 24: 43-51. PMID 29510390 DOI: 10.1159/000487767  0.598
2018 de Waal MM, Christ C, Dekker JJM, Kikkert MJ, Lommerse NM, van den Brink W, Goudriaan AE. Factors associated with victimization in dual diagnosis patients. Journal of Substance Abuse Treatment. 84: 68-77. PMID 29195595 DOI: 10.1016/j.jsat.2017.11.001  0.661
2017 Schulte MHJ, Wiers RW, Boendermaker WJ, Goudriaan AE, van den Brink W, van Deursen DS, Friese M, Brede E, Waters AJ. The effect of N-acetylcysteine and working memory training on cocaine use, craving and inhibition in regular cocaine users: correspondence of lab assessments and Ecological Momentary Assessment. Addictive Behaviors. 79: 24-31. PMID 29241082 DOI: 10.1016/J.Addbeh.2017.11.044  0.673
2017 Schluter RS, Jansen JM, van Holst RJ, van den Brink W, Goudriaan AE. Differential effects of left and right prefrontal high frequency rTMS on resting state fMRI in healthy individuals. Brain Connectivity. PMID 29237276 DOI: 10.1089/brain.2017.0542  0.777
2017 Schulte M, Goudriaan AE, Kaag AM, Kooi DP, van den Brink W, Wiers RW, Schmaal L. The effect of N-acetylcysteine on brain glutamate and gamma-aminobutyric acid concentrations and on smoking cessation: A randomized, double-blind, placebo-controlled trial. Journal of Psychopharmacology (Oxford, England). 269881117730660. PMID 28922968 DOI: 10.1177/0269881117730660  0.772
2017 Schulte MHJ, Kaag AM, Wiers RW, Schmaal L, van den Brink W, Reneman L, Homberg JR, van Wingen GA, Goudriaan AE. Prefrontal Glx and GABA concentrations and impulsivity in cigarette smokers and smoking polysubstance users. Drug and Alcohol Dependence. 179: 117-123. PMID 28763779 DOI: 10.1016/J.Drugalcdep.2017.06.025  0.785
2017 Koenders L, Lorenzetti V, de Haan L, Suo C, Vingerhoets W, van den Brink W, Wiers RW, Meijer CJ, Machielsen M, Goudriaan AE, Veltman DJ, Yücel M, Cousijn J. Longitudinal study of hippocampal volumes in heavy cannabis users. Journal of Psychopharmacology (Oxford, England). 269881117718380. PMID 28741422 DOI: 10.1177/0269881117718380  0.566
2017 Beraha EM, Salemink E, Goudriaan AE, van den Brink W, Wiers RW. Response to "Baclofen and alcohol use disorders: From miracle to mirage". European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 28576349 DOI: 10.1016/j.euroneuro.2017.05.002  0.679
2017 Machielsen MW, Veltman DJ, van den Brink W, de Haan L. Comparing the effect of clozapine and risperidone on cue reactivity in male patients with schizophrenia and a cannabis use disorder: A randomized fMRI study. Schizophrenia Research. PMID 28351544 DOI: 10.1016/J.Schres.2017.03.030  0.567
2016 Gevonden M, Myin-Germeys I, Wichers M, Booij J, van den Brink W, van Winkel R, Selten JP. Reactivity to social stress in ethnic minority men. Psychiatry Research. PMID 27884461 DOI: 10.1016/J.Psychres.2016.10.076  0.369
2016 Mattila T, Koeter M, Wohlfarth T, Storosum J, van den Brink W, Derks E, Leufkens H, Denys D. The impact of second generation antipsychotics on insight in schizophrenia: Results from 14 randomized, placebo controlled trials. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 27842941 DOI: 10.1016/J.Euroneuro.2016.10.004  0.556
2016 Beraha EM, Salemink E, Goudriaan AE, Bakker A, de Jong D, Smits N, Zwart JW, Geest DV, Bodewits P, Schiphof T, Defourny H, van Tricht M, van den Brink W, Wiers RW. Efficacy and safety of high-dose baclofen for the treatment of alcohol dependence: A multicentre, randomised, double-blind controlled trial. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 27842939 DOI: 10.1016/j.euroneuro.2016.10.006  0.64
2016 Welten CC, Koeter MW, Wohlfarth TD, Storosum JG, van den Brink W, Gispen-de Wied CC, Leufkens HG, Denys DA. Early Nonresponse in the Antipsychotic Treatment of Acute Mania: A Criterion for Reconsidering Treatment? Results From an Individual Patient Data Meta-Analysis. The Journal of Clinical Psychiatry. 77: e1117-e1123. PMID 27780320 DOI: 10.4088/JCP.15r10051  0.535
2016 Zaaijer ER, Goudriaan AE, Koeter MW, Booij J, van den Brink W. Acceptability of Extended-Release Naltrexone by Heroin-Dependent Patients and Addiction Treatment Providers in the Netherlands. Substance Use & Misuse. 1-7. PMID 27613150 DOI: 10.1080/10826084.2016.1201117  0.779
2016 Kaag AM, Schluter RS, Karel P, Homberg J, van den Brink W, Reneman L, van Wingen GA. Aversive Counterconditioning Attenuates Reward Signaling in the Ventral Striatum. Frontiers in Human Neuroscience. 10: 418. PMID 27594829 DOI: 10.3389/Fnhum.2016.00418  0.761
2016 Cohn MD, Viding E, McCrory E, Pape L, van den Brink W, Doreleijers TA, Veltman DJ, Popma A. Regional grey matter volume and concentration in at-risk adolescents: Untangling associations with callous-unemotional traits and conduct disorder symptoms. Psychiatry Research. 254: 180-187. PMID 27479922 DOI: 10.1016/J.Pscychresns.2016.07.003  0.54
2016 Luigjes J, Figee M, Tobler PN, van den Brink W, de Kwaasteniet B, van Wingen G, Denys D. Doubt in the Insula: Risk Processing in Obsessive-Compulsive Disorder. Frontiers in Human Neuroscience. 10: 283. PMID 27378883 DOI: 10.3389/Fnhum.2016.00283  0.782
2016 Koenders L, Cousijn J, Vingerhoets WA, van den Brink W, Wiers RW, Meijer CJ, Machielsen MW, Veltman DJ, Goudriaan AE, de Haan L. Grey Matter Changes Associated with Heavy Cannabis Use: A Longitudinal sMRI Study. Plos One. 11: e0152482. PMID 27224247 DOI: 10.1371/Journal.Pone.0152482  0.797
2016 Nuijten M, Blanken P, Van den Brink W, Goudriaan AE, Hendriks VM. Impulsivity and attentional bias as predictors of modafinil treatment outcome for retention and drug use in crack-cocaine dependent patients: Results of a randomised controlled trial. Journal of Psychopharmacology (Oxford, England). PMID 27147591 DOI: 10.1177/0269881116645268  0.671
2016 Kaag AM, Levar N, Woutersen K, Homberg J, van den Brink W, Reneman L, van Wingen G. Hyperresponsiveness of the Neural Fear Network During Fear Conditioning and Extinction Learning in Male Cocaine Users. The American Journal of Psychiatry. appiajp201615040433. PMID 27079132 DOI: 10.1176/Appi.Ajp.2016.15040433  0.762
2016 Kaye S, Ramos-Quiroga JA, van de Glind G, Levin FR, Faraone SV, Allsop S, Degenhardt L, Moggi F, Barta C, Konstenius M, Franck J, Skutle A, Bu ET, Koeter MW, Demetrovics Z, ... ... van den Brink W, et al. Persistence and Subtype Stability of ADHD Among Substance Use Disorder Treatment Seekers. Journal of Attention Disorders. PMID 26922805 DOI: 10.1177/1087054716629217  0.594
2016 Kaag AM, van Wingen GA, Caan MW, Homberg JR, van den Brink W, Reneman L. White matter alterations in cocaine users are negatively related to the number of additionally (ab)used substances. Addiction Biology. PMID 26860848 DOI: 10.1111/Adb.12375  0.774
2015 Figee M, Pattij T, Willuhn I, Luigjes J, van den Brink W, Goudriaan A, Potenza MN, Robbins TW, Denys D. Compulsivity in obsessive-compulsive disorder and addictions. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 26774279 DOI: 10.1016/J.Euroneuro.2015.12.003  0.802
2015 Sjoerds Z, Stufflebeam SM, Veltman DJ, Van den Brink W, Penninx BW, Douw L. Loss of brain graph network efficiency in alcohol dependence. Addiction Biology. PMID 26692359 DOI: 10.1111/Adb.12346  0.791
2015 Welten CC, Koeter MW, Wohlfarth TD, Storosum JG, van den Brink W, Gispen-de Wied CC, Leufkens HG, Denys DA. Does Insight Affect the Efficacy of Antipsychotics in Acute Mania?: An Individual Patient Data Regression Meta-Analysis. Journal of Clinical Psychopharmacology. PMID 26647231 DOI: 10.1097/JCP.0000000000000435  0.573
2015 Vingerhoets W, Koenders L, van den Brink W, Wiers RW, Goudriaan AE, van Amelsvoort T, de Haan L, Cousijn J. Cue-induced striatal activity in frequent cannabis users independently predicts cannabis problem severity three years later. Journal of Psychopharmacology (Oxford, England). PMID 26645206 DOI: 10.1177/0269881115620436  0.781
2015 Pape LE, Cohn MD, Caan MW, van Wingen G, van den Brink W, Veltman DJ, Popma A. Psychopathic traits in adolescents are associated with higher structural connectivity. Psychiatry Research. 233: 474-80. PMID 26272037 DOI: 10.1016/J.Pscychresns.2015.07.023  0.542
2015 Stringer S, Cerrone KC, van den Brink W, van den Berg JF, Denys D, Kahn RS, Derks EM. A guide on gene prioritization in studies of psychiatric disorders. International Journal of Methods in Psychiatric Research. PMID 26230968 DOI: 10.1002/Mpr.1482  0.538
2015 Crunelle CL, Kaag AM, van den Munkhof HE, Reneman L, Homberg JR, Sabbe B, van den Brink W, van Wingen G. Dysfunctional amygdala activation and connectivity with the prefrontal cortex in current cocaine users. Human Brain Mapping. 36: 4222-30. PMID 26220024 DOI: 10.1002/Hbm.22913  0.797
2015 Welten CC, Koeter MW, Wohlfarth TD, Storosum JG, van den Brink W, Gispen-de Wied CC, Leufkens HG, Denys DA. Net gain analysis, an addition to responder analysis - The case of antipsychotic treatment of acute mania. Regulatory Toxicology and Pharmacology : Rtp. 73: 227-31. PMID 26164267 DOI: 10.1016/j.yrtph.2015.06.020  0.541
2015 Welten CC, Koeter MW, Wohlfarth TD, Storosum JG, van den Brink W, Gispen-de Wied CC, Leufkens HG, Denys DA. Efficacy of drug treatment for acute mania differs across geographic regions: An individual patient data meta-analysis of placebo-controlled studies. Journal of Psychopharmacology (Oxford, England). 29: 923-32. PMID 26038109 DOI: 10.1177/0269881115586938  0.573
2015 Welten CC, Koeter MW, Wohlfarth T, Storosum JG, van den Brink W, Gispen-de Wied CC, Leufkens HG, Denys DA. Placebo response in antipsychotic trials of patients with acute mania: Results of an individual patient data meta-analysis. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 25: 1018-26. PMID 25907248 DOI: 10.1016/j.euroneuro.2015.03.010  0.567
2015 Luigjes J, van den Brink W, Schuurman PR, Kuhn J, Denys D. Is deep brain stimulation a treatment option for addiction? Addiction (Abingdon, England). 110: 547-8. PMID 25771687 DOI: 10.1111/Add.12773  0.748
2015 Cohn MD, Pape LE, Schmaal L, van den Brink W, van Wingen G, Vermeiren RR, Doreleijers TA, Veltman DJ, Popma A. Differential relations between juvenile psychopathic traits and resting state network connectivity. Human Brain Mapping. 36: 2396-405. PMID 25757797 DOI: 10.1002/Hbm.22779  0.746
2015 Zaaijer ER, van Dijk L, de Bruin K, Goudriaan AE, Lammers LA, Koeter MW, van den Brink W, Booij J. Effect of extended-release naltrexone on striatal dopamine transporter availability, depression and anhedonia in heroin-dependent patients. Psychopharmacology. 232: 2597-607. PMID 25757673 DOI: 10.1007/S00213-015-3891-4  0.786
2015 Zaaijer ER, de Bruin K, la Fleur SE, Goudriaan AE, van den Brink W, Booij J. Subchronic administration of short-acting naltrexone has no effect on striatal dopamine transporter availability, food intake or body weight gain in rats. Journal of Psychopharmacology (Oxford, England). 29: 344-8. PMID 25586403 DOI: 10.1177/0269881114565380  0.778
2015 Mattila T, Koeter M, Wohlfarth T, Storosum J, van den Brink W, de Haan L, Derks E, Leufkens H, Denys D. Impact of DSM-5 changes on the diagnosis and acute treatment of schizophrenia. Schizophrenia Bulletin. 41: 637-43. PMID 25528758 DOI: 10.1093/Schbul/Sbu172  0.541
2015 Koenders L, Machielsen MW, van der Meer FJ, van Gasselt AC, Meijer CJ, van den Brink W, Koeter MW, Caan MW, Cousijn J, den Braber A, van 't Ent D, Rive MM, Schene AH, van de Giessen E, Huyser C, et al. Brain volume in male patients with recent onset schizophrenia with and without cannabis use disorders. Journal of Psychiatry & Neuroscience : Jpn. 40: 197-206. PMID 25510948 DOI: 10.1503/Jpn.140081  0.784
2015 Gevonden MJ, Myin-Germeys I, van den Brink W, van Os J, Selten JP, Booij J. Psychotic reactions to daily life stress and dopamine function in people with severe hearing impairment. Psychological Medicine. 45: 1665-74. PMID 25482840 DOI: 10.1017/S0033291714002797  0.435
2015 Bongers P, van de Giessen E, Roefs A, Nederkoorn C, Booij J, van den Brink W, Jansen A. Being impulsive and obese increases susceptibility to speeded detection of high-calorie foods. Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association. 34: 677-85. PMID 25365413 DOI: 10.1037/Hea0000167  0.674
2015 Heytens L, Neels H, Van Regenmortel N, van den Brink W, Henckes M, Schouwers S, Dockx G, Crunelle CL. Near-fatal persistent anion- and osmolal-gap acidosis due to massive gamma-butyrolactone/ethanol intoxication. Annals of Clinical Biochemistry. 52: 283-7. PMID 25205856 DOI: 10.1177/0004563214553278  0.538
2015 Jansen JM, van der Werf YD, van den Heuvel OA, de Wit SJ, van den Brink W, Goudriaan AE. Niet-invasieve hersenstimulatie bij verslaving; het effect op craving en emotieregulatie Neuropraxis. 19: 54-58. DOI: 10.1007/s12474-015-0080-5  0.631
2014 Cohn MD, Veltman DJ, Pape LE, van Lith K, Vermeiren RR, van den Brink W, Doreleijers TA, Popma A. Incentive Processing in Persistent Disruptive Behavior and Psychopathic Traits: A Functional Magnetic Resonance Imaging Study in Adolescents. Biological Psychiatry. PMID 25497690 DOI: 10.1016/J.Biopsych.2014.08.017  0.55
2014 Jansen JM, van Holst RJ, van den Brink W, Veltman DJ, Caan MW, Goudriaan AE. Brain function during cognitive flexibility and white matter integrity in alcohol-dependent patients, problematic drinkers and healthy controls. Addiction Biology. PMID 25477246 DOI: 10.1111/Adb.12199  0.8
2014 Zaaijer ER, Bruijel J, Blanken P, Hendriks V, Koeter MW, Kreek MJ, Booij J, Goudriaan AE, van Ree JM, van den Brink W. Personality as a risk factor for illicit opioid use and a protective factor for illicit opioid dependence. Drug and Alcohol Dependence. 145: 101-5. PMID 25454407 DOI: 10.1016/J.Drugalcdep.2014.09.783  0.764
2014 Romanczuk-Seiferth N, van den Brink W, Goudriaan AE. From symptoms to neurobiology: pathological gambling in the light of the new classification in DSM-5. Neuropsychobiology. 70: 95-102. PMID 25359489 DOI: 10.1159/000362839  0.676
2014 Merkx MJ, Schippers GM, Koeter MW, De Wildt WA, Vedel E, Goudriaan AE, Van Den Brink W. Treatment outcome of alcohol use disorder outpatients with or without medically assisted detoxification. Journal of Studies On Alcohol and Drugs. 75: 993-8. PMID 25343657 DOI: 10.15288/jsad.2014.75.993  0.673
2014 Kaag AM, Crunelle CL, van Wingen G, Homberg J, van den Brink W, Reneman L. Relationship between trait impulsivity and cortical volume, thickness and surface area in male cocaine users and non-drug using controls. Drug and Alcohol Dependence. 144: 210-7. PMID 25278147 DOI: 10.1016/J.Drugalcdep.2014.09.016  0.787
2014 Gevonden M, Booij J, van den Brink W, Heijtel D, van Os J, Selten JP. Increased release of dopamine in the striata of young adults with hearing impairment and its relevance for the social defeat hypothesis of schizophrenia. Jama Psychiatry. 71: 1364-72. PMID 25271822 DOI: 10.1001/Jamapsychiatry.2014.1325  0.4
2014 Schulte MH, Cousijn J, den Uyl TE, Goudriaan AE, van den Brink W, Veltman DJ, Schilt T, Wiers RW. Recovery of neurocognitive functions following sustained abstinence after substance dependence and implications for treatment. Clinical Psychology Review. 34: 531-50. PMID 25240109 DOI: 10.1016/J.Cpr.2014.08.002  0.794
2014 Schmaal L, Goudriaan AE, Joos L, Dom G, Pattij T, van den Brink W, Veltman DJ. Neural substrates of impulsive decision making modulated by modafinil in alcohol-dependent patients. Psychological Medicine. 44: 2787-98. PMID 25066449 DOI: 10.1017/S0033291714000312  0.799
2014 van Holst RJ, Clark L, Veltman DJ, van den Brink W, Goudriaan AE. Enhanced striatal responses during expectancy coding in alcohol dependence. Drug and Alcohol Dependence. 142: 204-8. PMID 25012896 DOI: 10.1016/J.Drugalcdep.2014.06.019  0.79
2014 Kräplin A, Bühringer G, Oosterlaan J, van den Brink W, Goschke T, Goudriaan AE. Dimensions and disorder specificity of impulsivity in pathological gambling. Addictive Behaviors. 39: 1646-51. PMID 24930455 DOI: 10.1016/J.Addbeh.2014.05.021  0.681
2014 Vanes LD, van Holst RJ, Jansen JM, van den Brink W, Oosterlaan J, Goudriaan AE. Contingency learning in alcohol dependence and pathological gambling: learning and unlearning reward contingencies. Alcoholism, Clinical and Experimental Research. 38: 1602-10. PMID 24821534 DOI: 10.1111/Acer.12393  0.771
2014 van de Giessen E, Celik F, Schweitzer DH, van den Brink W, Booij J. Dopamine D2/3 receptor availability and amphetamine-induced dopamine release in obesity. Journal of Psychopharmacology (Oxford, England). 28: 866-73. PMID 24785761 DOI: 10.1177/0269881114531664  0.667
2014 Crunelle CL, van den Brink W, Dom G, Booij J. Dopamine transporter occupancy by methylphenidate and impulsivity in adult ADHD. The British Journal of Psychiatry : the Journal of Mental Science. 204: 486-7. PMID 24676965 DOI: 10.1192/Bjp.Bp.113.132977  0.66
2014 Mattila T, Wohlfarth T, Koeter M, Storosum J, van den Brink W, de Haan L, Leufkens H, Denys D. Geographic variation in efficacy of atypical antipsychotics for the acute treatment of schizophrenia - an individual patient data meta-analysis. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 24: 1067-77. PMID 24661547 DOI: 10.1016/J.Euroneuro.2014.02.006  0.547
2014 Machielsen MW, Veltman DJ, van den Brink W, de Haan L. The effect of clozapine and risperidone on attentional bias in patients with schizophrenia and a cannabis use disorder: An fMRI study. Journal of Psychopharmacology (Oxford, England). 28: 633-642. PMID 24646809 DOI: 10.1177/0269881114527357  0.582
2014 Cousijn J, Vingerhoets WA, Koenders L, de Haan L, van den Brink W, Wiers RW, Goudriaan AE. Relationship between working-memory network function and substance use: a 3-year longitudinal fMRI study in heavy cannabis users and controls. Addiction Biology. 19: 282-93. PMID 24589297 DOI: 10.1111/Adb.12111  0.764
2014 Sjoerds Z, Luigjes J, van den Brink W, Denys D, Yücel M. The role of habits and motivation in human drug addiction: a reflection. Frontiers in Psychiatry. 5: 8. PMID 24523702 DOI: 10.3389/Fpsyt.2014.00008  0.782
2014 Boschloo L, van den Brink W, Penninx BW. Does self-medication predict the persistence or rather the recurrence of alcohol dependence? Jama Psychiatry. 71: 205. PMID 24500625 DOI: 10.1001/jamapsychiatry.2013.2985  0.481
2014 Crunelle CL, Kaag AM, van Wingen G, van den Munkhof HE, Homberg JR, Reneman L, van den Brink W. Reduced frontal brain volume in non-treatment-seeking cocaine-dependent individuals: exploring the role of impulsivity, depression, and smoking. Frontiers in Human Neuroscience. 8: 7. PMID 24478673 DOI: 10.3389/Fnhum.2014.00007  0.795
2014 Sjoerds Z, van den Brink W, Beekman AT, Penninx BW, Veltman DJ. Cue reactivity is associated with duration and severity of alcohol dependence: an FMRI study. Plos One. 9: e84560. PMID 24400099 DOI: 10.1371/Journal.Pone.0084560  0.803
2014 Cousijn J, Wiers RW, Ridderinkhof KR, van den Brink W, Veltman DJ, Goudriaan AE. Effect of baseline cannabis use and working-memory network function on changes in cannabis use in heavy cannabis users: a prospective fMRI study. Human Brain Mapping. 35: 2470-82. PMID 24038570 DOI: 10.1002/Hbm.22342  0.787
2014 Sjoerds Z, van den Brink W, Beekman AT, Penninx BW, Veltman DJ. Response inhibition in alcohol-dependent patients and patients with depression/anxiety: a functional magnetic resonance imaging study. Psychological Medicine. 44: 1713-25. PMID 24016382 DOI: 10.1017/S0033291713002274  0.8
2013 Boschloo L, Vogelzangs N, van den Brink W, Smit JH, Veltman DJ, Beekman AT, Penninx BW. Depressive and anxiety disorders predicting first incidence of alcohol use disorders: results of the Netherlands Study of Depression and Anxiety (NESDA). The Journal of Clinical Psychiatry. 74: 1233-40. PMID 24434092 DOI: 10.4088/Jcp.12M08159  0.696
2013 Sjoerds Z, de Wit S, van den Brink W, Robbins TW, Beekman AT, Penninx BW, Veltman DJ. Behavioral and neuroimaging evidence for overreliance on habit learning in alcohol-dependent patients. Translational Psychiatry. 3: e337. PMID 24346135 DOI: 10.1038/Tp.2013.107  0.803
2013 Cohn MD, Popma A, van den Brink W, Pape LE, Kindt M, van Domburgh L, Doreleijers TA, Veltman DJ. Fear conditioning, persistence of disruptive behavior and psychopathic traits: an fMRI study. Translational Psychiatry. 3: e319. PMID 24169638 DOI: 10.1038/Tp.2013.89  0.581
2013 Joos L, Goudriaan AE, Schmaal L, van den Brink W, Sabbe BG, Dom G. Effect of modafinil on cognitive functions in alcohol dependent patients: a randomized, placebo-controlled trial. Journal of Psychopharmacology (Oxford, England). 27: 998-1006. PMID 24045883 DOI: 10.1177/0269881113503505  0.788
2013 Jansen JM, Daams JG, Koeter MW, Veltman DJ, van den Brink W, Goudriaan AE. Effects of non-invasive neurostimulation on craving: a meta-analysis. Neuroscience and Biobehavioral Reviews. 37: 2472-80. PMID 23916527 DOI: 10.1016/J.Neubiorev.2013.07.009  0.784
2013 Crunelle CL, van den Brink W, Veltman DJ, van Emmerik-van Oortmerssen K, Dom G, Schoevers RA, Booij J. Low dopamine transporter occupancy by methylphenidate as a possible reason for reduced treatment effectiveness in ADHD patients with cocaine dependence. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 1714-23. PMID 23731497 DOI: 10.1016/J.Euroneuro.2013.05.002  0.764
2013 van Wingen GA, van den Brink W, Veltman DJ, Schmaal L, Dom G, Booij J, Crunelle CL. Reduced striatal brain volumes in non-medicated adult ADHD patients with comorbid cocaine dependence. Drug and Alcohol Dependence. 131: 198-203. PMID 23726981 DOI: 10.1016/J.Drugalcdep.2013.05.007  0.794
2013 Starcke K, van Holst RJ, van den Brink W, Veltman DJ, Goudriaan AE. Physiological and endocrine reactions to psychosocial stress in alcohol use disorders: duration of abstinence matters. Alcoholism, Clinical and Experimental Research. 37: 1343-50. PMID 23488992 DOI: 10.1111/Acer.12103  0.782
2013 Figee M, Luigjes J, Smolders R, Valencia-Alfonso CE, van Wingen G, de Kwaasteniet B, Mantione M, Ooms P, de Koning P, Vulink N, Levar N, Droge L, van den Munckhof P, Schuurman PR, Nederveen A, ... van den Brink W, et al. Deep brain stimulation restores frontostriatal network activity in obsessive-compulsive disorder. Nature Neuroscience. 16: 386-7. PMID 23434914 DOI: 10.1038/Nn.3344  0.796
2013 Schmaal L, Goudriaan AE, Joos L, Krüse AM, Dom G, van den Brink W, Veltman DJ. Modafinil modulates resting-state functional network connectivity and cognitive control in alcohol-dependent patients. Biological Psychiatry. 73: 789-95. PMID 23399373 DOI: 10.1016/J.Biopsych.2012.12.025  0.796
2013 Schouw ML, De Ruiter MB, Kaag AM, van den Brink W, Lindauer RJ, Reneman L. Dopaminergic dysfunction in abstinent dexamphetamine users: results from a pharmacological fMRI study using a reward anticipation task and a methylphenidate challenge. Drug and Alcohol Dependence. 130: 52-60. PMID 23142493 DOI: 10.1016/J.Drugalcdep.2012.10.010  0.776
2013 Joos L, Goudriaan AE, Schmaal L, Fransen E, van den Brink W, Sabbe BG, Dom G. Effect of modafinil on impulsivity and relapse in alcohol dependent patients: a randomized, placebo-controlled trial. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 948-55. PMID 23141152 DOI: 10.1016/J.Euroneuro.2012.10.004  0.803
2013 Joos L, Goudriaan AE, Schmaal L, De Witte NA, Van den Brink W, Sabbe BG, Dom G. The relationship between impulsivity and craving in alcohol dependent patients. Psychopharmacology. 226: 273-83. PMID 23096771 DOI: 10.1007/S00213-012-2905-8  0.804
2013 Sjoerds Z, van Tol MJ, van den Brink W, van der Wee NJ, Aleman A, Beekman AT, Penninx BW, Veltman DJ. Family history of alcohol dependence modulates functional neurophysiology in mood/anxiety disorders. Psychological Medicine. 43: 1487-97. PMID 23036336 DOI: 10.1017/S003329171200222X  0.808
2013 Crunelle CL, Veltman DJ, van Emmerik-van Oortmerssen K, Booij J, van den Brink W. Impulsivity in adult ADHD patients with and without cocaine dependence. Drug and Alcohol Dependence. 129: 18-24. PMID 23026814 DOI: 10.1016/J.Drugalcdep.2012.09.006  0.768
2013 Joos L, Schmaal L, Goudriaan AE, Fransen E, Van den Brink W, Sabbe BG, Dom G. Age of onset and neuropsychological functioning in alcohol dependent inpatients. Alcoholism, Clinical and Experimental Research. 37: 407-16. PMID 23025636 DOI: 10.1111/J.1530-0277.2012.01949.X  0.799
2013 Boschloo L, Vogelzangs N, van den Brink W, Smit JH, Beekman AT, Penninx BW. The role of negative emotionality and impulsivity in depressive/anxiety disorders and alcohol dependence. Psychological Medicine. 43: 1241-53. PMID 23020956 DOI: 10.1017/S0033291712002152  0.527
2013 Cousijn J, Wiers RW, Ridderinkhof KR, van den Brink W, Veltman DJ, Porrino LJ, Goudriaan AE. Individual differences in decision making and reward processing predict changes in cannabis use: a prospective functional magnetic resonance imaging study. Addiction Biology. 18: 1013-23. PMID 22994937 DOI: 10.1111/J.1369-1600.2012.00498.X  0.803
2013 van de Giessen E, la Fleur SE, Eggels L, de Bruin K, van den Brink W, Booij J. High fat/carbohydrate ratio but not total energy intake induces lower striatal dopamine D2/3 receptor availability in diet-induced obesity. International Journal of Obesity (2005). 37: 754-7. PMID 22868829 DOI: 10.1038/Ijo.2012.128  0.661
2013 Schmaal L, Joos L, Koeleman M, Veltman DJ, van den Brink W, Goudriaan AE. Effects of modafinil on neural correlates of response inhibition in alcohol-dependent patients. Biological Psychiatry. 73: 211-8. PMID 22858150 DOI: 10.1016/J.Biopsych.2012.06.032  0.802
2013 Goudriaan AE, Veltman DJ, van den Brink W, Dom G, Schmaal L. Neurophysiological effects of modafinil on cue-exposure in cocaine dependence: a randomized placebo-controlled cross-over study using pharmacological fMRI. Addictive Behaviors. 38: 1509-17. PMID 22591950 DOI: 10.1016/J.Addbeh.2012.04.006  0.804
2013 Sjoerds Z, Van Tol MJ, Van den Brink W, Van der Wee NJ, Van Buchem MA, Aleman A, Penninx BW, Veltman DJ. Family history of alcohol dependence and gray matter abnormalities in non-alcoholic adults. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 14: 565-73. PMID 22283466 DOI: 10.3109/15622975.2011.640942  0.795
2013 Cousijn J, Goudriaan AE, Ridderinkhof KR, van den Brink W, Veltman DJ, Wiers RW. Neural responses associated with cue-reactivity in frequent cannabis users. Addiction Biology. 18: 570-80. PMID 22264344 DOI: 10.1111/J.1369-1600.2011.00417.X  0.802
2013 Crunelle CL, van de Giessen E, Schulz S, Vanderschuren LJ, de Bruin K, van den Brink W, Booij J. Cannabinoid-1 receptor antagonist rimonabant (SR141716) increases striatal dopamine D2 receptor availability. Addiction Biology. 18: 908-11. PMID 21955259 DOI: 10.1111/J.1369-1600.2011.00369.X  0.766
2012 Schierenberg A, van Amsterdam J, van den Brink W, Goudriaan AE. Efficacy of contingency management for cocaine dependence treatment: a review of the evidence. Current Drug Abuse Reviews. 5: 320-31. PMID 23244344 DOI: 10.2174/1874473711205040006  0.665
2012 van Holst RJ, van der Meer JN, McLaren DG, van den Brink W, Veltman DJ, Goudriaan AE. Interactions between affective and cognitive processing systems in problematic gamblers: a functional connectivity study. Plos One. 7: e49923. PMID 23209619 DOI: 10.1371/Journal.Pone.0049923  0.79
2012 Schmaal L, Goudriaan AE, van der Meer J, van den Brink W, Veltman DJ. The association between cingulate cortex glutamate concentration and delay discounting is mediated by resting state functional connectivity. Brain and Behavior. 2: 553-62. PMID 23139901 DOI: 10.1002/Brb3.74  0.796
2012 Cousijn J, Goudriaan AE, Ridderinkhof KR, van den Brink W, Veltman DJ, Wiers RW. Approach-bias predicts development of cannabis problem severity in heavy cannabis users: results from a prospective FMRI study. Plos One. 7: e42394. PMID 22957019 DOI: 10.1371/Journal.Pone.0042394  0.797
2012 Crunelle CL, Veltman DJ, Booij J, Emmerik-van Oortmerssen K, van den Brink W. Substrates of neuropsychological functioning in stimulant dependence: a review of functional neuroimaging research. Brain and Behavior. 2: 499-523. PMID 22950052 DOI: 10.1002/Brb3.65  0.78
2012 van Holst RJ, Veltman DJ, van den Brink W, Goudriaan AE. Right on cue? Striatal reactivity in problem gamblers. Biological Psychiatry. 72: e23-4. PMID 22795970 DOI: 10.1016/J.Biopsych.2012.06.017  0.761
2012 Reneman L, de Win MM, Booij J, van den Brink W, den Heeten GJ, Freling N, Majoie CB. Incidental head and neck findings on MRI in young healthy volunteers: prevalence and clinical implications. Ajnr. American Journal of Neuroradiology. 33: 1971-4. PMID 22723061 DOI: 10.3174/Ajnr.A3217  0.604
2012 Broos N, Schmaal L, Wiskerke J, Kostelijk L, Lam T, Stoop N, Weierink L, Ham J, de Geus EJ, Schoffelmeer AN, van den Brink W, Veltman DJ, de Vries TJ, Pattij T, Goudriaan AE. The relationship between impulsive choice and impulsive action: a cross-species translational study. Plos One. 7: e36781. PMID 22574225 DOI: 10.1371/Journal.Pone.0036781  0.787
2012 Schmaal L, Veltman DJ, Nederveen A, van den Brink W, Goudriaan AE. N-acetylcysteine normalizes glutamate levels in cocaine-dependent patients: a randomized crossover magnetic resonance spectroscopy study. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 2143-52. PMID 22549117 DOI: 10.1038/Npp.2012.66  0.8
2012 van Holst RJ, van Holstein M, van den Brink W, Veltman DJ, Goudriaan AE. Response inhibition during cue reactivity in problem gamblers: an fMRI study. Plos One. 7: e30909. PMID 22479305 DOI: 10.1371/Journal.Pone.0030909  0.792
2012 van de Giessen E, Nimgaonkar VL, Watson AM, Kodavali C, Baas F, Tanck MW, de Win MM, van den Brink W, Booij J. Association tests of striatal DAT availability and SNPs that impact a novel splice variant in the DAT gene. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 53: 839. PMID 22427685 DOI: 10.2967/Jnumed.111.100271  0.66
2012 Boschloo L, Vogelzangs N, van den Brink W, Smit JH, Beekman AT, Penninx BW. Predictors of the 2-year recurrence and persistence of alcohol dependence. Addiction (Abingdon, England). 107: 1639-40. PMID 22372473 DOI: 10.1111/J.1360-0443.2012.03860.X  0.532
2012 van Holst RJ, Veltman DJ, Büchel C, van den Brink W, Goudriaan AE. Distorted expectancy coding in problem gambling: is the addictive in the anticipation? Biological Psychiatry. 71: 741-8. PMID 22342105 DOI: 10.1016/J.Biopsych.2011.12.030  0.79
2012 Boschloo L, Vogelzangs N, van den Brink W, Smit JH, Veltman DJ, Beekman AT, Penninx BW. Alcohol use disorders and the course of depressive and anxiety disorders. The British Journal of Psychiatry : the Journal of Mental Science. 200: 476-84. PMID 22322459 DOI: 10.1192/Bjp.Bp.111.097550  0.694
2012 van de Giessen E, la Fleur SE, de Bruin K, van den Brink W, Booij J. Free-choice and no-choice high-fat diets affect striatal dopamine D2/3 receptor availability, caloric intake, and adiposity. Obesity (Silver Spring, Md.). 20: 1738-40. PMID 22307070 DOI: 10.1038/Oby.2012.17  0.665
2012 Valencia-Alfonso CE, Luigjes J, Smolders R, Cohen MX, Levar N, Mazaheri A, van den Munckhof P, Schuurman PR, van den Brink W, Denys D. Effective deep brain stimulation in heroin addiction: a case report with complementary intracranial electroencephalogram. Biological Psychiatry. 71: e35-7. PMID 22281120 DOI: 10.1016/J.Biopsych.2011.12.013  0.739
2012 van Holst RJ, de Ruiter MB, van den Brink W, Veltman DJ, Goudriaan AE. A voxel-based morphometry study comparing problem gamblers, alcohol abusers, and healthy controls. Drug and Alcohol Dependence. 124: 142-8. PMID 22270405 DOI: 10.1016/J.Drugalcdep.2011.12.025  0.809
2012 Crunelle CL, de Wit TC, de Bruin K, Ramakers RM, van der Have F, Beekman FJ, van den Brink W, Booij J. Varenicline increases in vivo striatal dopamine D2/3 receptor binding: an ultra-high-resolution pinhole [123I]IBZM SPECT study in rats. Nuclear Medicine and Biology. 39: 640-4. PMID 22261145 DOI: 10.1016/J.Nucmedbio.2011.11.006  0.662
2012 van Emmerik-van Oortmerssen K, van de Glind G, van den Brink W, Smit F, Crunelle CL, Swets M, Schoevers RA. Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: a meta-analysis and meta-regression analysis. Drug and Alcohol Dependence. 122: 11-9. PMID 22209385 DOI: 10.1016/J.Drugalcdep.2011.12.007  0.621
2012 Veldhuis J, Dieleman JP, Wohlfarth T, Storosum JG, van Den Brink W, Sturkenboom MC, Denys D. Incidence and prevalence of "diagnosed OCD" in a primary care, treatment seeking, population. International Journal of Psychiatry in Clinical Practice. 16: 85-92. PMID 22122660 DOI: 10.3109/13651501.2011.617454  0.547
2012 Cousijn J, Wiers RW, Ridderinkhof KR, van den Brink W, Veltman DJ, Goudriaan AE. Grey matter alterations associated with cannabis use: results of a VBM study in heavy cannabis users and healthy controls. Neuroimage. 59: 3845-51. PMID 21982932 DOI: 10.1016/J.Neuroimage.2011.09.046  0.802
2012 Luigjes J, van den Brink W, Feenstra M, van den Munckhof P, Schuurman PR, Schippers R, Mazaheri A, De Vries TJ, Denys D. Deep brain stimulation in addiction: a review of potential brain targets. Molecular Psychiatry. 17: 572-83. PMID 21931318 DOI: 10.1038/Mp.2011.114  0.757
2012 de Ruiter MB, Oosterlaan J, Veltman DJ, van den Brink W, Goudriaan AE. Similar hyporesponsiveness of the dorsomedial prefrontal cortex in problem gamblers and heavy smokers during an inhibitory control task. Drug and Alcohol Dependence. 121: 81-9. PMID 21893386 DOI: 10.1016/J.Drugalcdep.2011.08.010  0.783
2012 van de Giessen E, de Bruin K, la Fleur SE, van den Brink W, Booij J. Triple monoamine inhibitor tesofensine decreases food intake, body weight, and striatal dopamine D2/D3 receptor availability in diet-induced obese rats. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 22: 290-9. PMID 21889317 DOI: 10.1016/J.Euroneuro.2011.07.015  0.668
2012 Boschloo L, van den Brink W, Penninx BW, Wall MM, Hasin DS. Alcohol-use disorder severity predicts first-incidence of depressive disorders. Psychological Medicine. 42: 695-703. PMID 21867593 DOI: 10.1017/S0033291711001681  0.538
2012 Boschloo L, Vogelzangs N, Van Den Brink W, Smit JH, Veltman DJ, Beekman ATF, Penninx BWJH. Authors' reply: British Journal of Psychiatry. 201: 326-327. DOI: 10.1192/bjp.201.4.326a  0.475
2011 Luigjes J, Mantione M, van den Brink W, Schuurman PR, van den Munckhof P, Denys D. Deep brain stimulation increases impulsivity in two patients with obsessive-compulsive disorder. International Clinical Psychopharmacology. 26: 338-40. PMID 21857527 DOI: 10.1097/Yic.0B013E32834Af505  0.757
2011 Blom RM, Koeter M, van den Brink W, de Graaf R, Ten Have M, Denys D. Co-occurrence of obsessive-compulsive disorder and substance use disorder in the general population. Addiction (Abingdon, England). 106: 2178-85. PMID 21714825 DOI: 10.1111/J.1360-0443.2011.03559.X  0.577
2011 Schmaal L, Berk L, Hulstijn KP, Cousijn J, Wiers RW, van den Brink W. Efficacy of N-acetylcysteine in the treatment of nicotine dependence: a double-blind placebo-controlled pilot study. European Addiction Research. 17: 211-6. PMID 21606648 DOI: 10.1159/000327682  0.745
2011 van de Giessen E, Groot PF, Booij J, van den Brink W, Veltman DJ, Nederveen AJ. Functional MR imaging on an open 1T MR imaging system: exploiting the advantages of an open MR imaging system for functional MR imaging. Ajnr. American Journal of Neuroradiology. 32: 903-7. PMID 21330391 DOI: 10.3174/ajnr.A2383  0.748
2011 Boschloo L, Vogelzangs N, Licht CM, Vreeburg SA, Smit JH, van den Brink W, Veltman DJ, de Geus EJ, Beekman AT, Penninx BW. Heavy alcohol use, rather than alcohol dependence, is associated with dysregulation of the hypothalamic-pituitary-adrenal axis and the autonomic nervous system. Drug and Alcohol Dependence. 116: 170-6. PMID 21330066 DOI: 10.1016/J.Drugalcdep.2010.12.006  0.686
2011 Boschloo L, Vogelzangs N, Smit JH, van den Brink W, Veltman DJ, Beekman AT, Penninx BW. Comorbidity and risk indicators for alcohol use disorders among persons with anxiety and/or depressive disorders: findings from the Netherlands Study of Depression and Anxiety (NESDA). Journal of Affective Disorders. 131: 233-42. PMID 21247636 DOI: 10.1016/J.Jad.2010.12.014  0.69
2011 Crunelle CL, Schulz S, de Bruin K, Miller ML, van den Brink W, Booij J. Dose-dependent and sustained effects of varenicline on dopamine D2/3 receptor availability in rats. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 21: 205-10. PMID 21130610 DOI: 10.1016/J.Euroneuro.2010.11.001  0.661
2011 Luijten M, Veltman DJ, van den Brink W, Hester R, Field M, Smits M, Franken IH. Neurobiological substrate of smoking-related attentional bias. Neuroimage. 54: 2374-81. PMID 20932921 DOI: 10.1016/J.Neuroimage.2010.09.064  0.574
2011 Burke SM, van de Giessen E, de Win M, Schilt T, van Herk M, van den Brink W, Booij J. Serotonin and dopamine transporters in relation to neuropsychological functioning, personality traits and mood in young adult healthy subjects. Psychological Medicine. 41: 419-29. PMID 20367893 DOI: 10.1017/S0033291710000486  0.704
2010 Goudriaan AE, de Ruiter MB, van den Brink W, Oosterlaan J, Veltman DJ. Brain activation patterns associated with cue reactivity and craving in abstinent problem gamblers, heavy smokers and healthy controls: an fMRI study. Addiction Biology. 15: 491-503. PMID 20840335 DOI: 10.1111/J.1369-1600.2010.00242.X  0.764
2010 van Holst RJ, van den Brink W, Veltman DJ, Goudriaan AE. Brain imaging studies in pathological gambling. Current Psychiatry Reports. 12: 418-25. PMID 20676945 DOI: 10.1007/S11920-010-0141-7  0.792
2010 Boschloo L, Vogelzangs N, Smit JH, van den Brink W, Veltman DJ, Beekman AT, Penninx BW. The performance of the Alcohol Use Disorder Identification Test (AUDIT) in detecting alcohol abuse and dependence in a population of depressed or anxious persons. Journal of Affective Disorders. 126: 441-6. PMID 20537398 DOI: 10.1016/J.Jad.2010.04.019  0.693
2010 Crunelle CL, Miller ML, Booij J, van den Brink W. The nicotinic acetylcholine receptor partial agonist varenicline and the treatment of drug dependence: a review. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 20: 69-79. PMID 19959340 DOI: 10.1016/J.Euroneuro.2009.11.001  0.673
2010 van Holst RJ, van den Brink W, Veltman DJ, Goudriaan AE. Why gamblers fail to win: a review of cognitive and neuroimaging findings in pathological gambling. Neuroscience and Biobehavioral Reviews. 34: 87-107. PMID 19632269 DOI: 10.1016/J.Neubiorev.2009.07.007  0.794
2009 Crunelle CL, Miller ML, de Bruin K, van den Brink W, Booij J. Varenicline increases striatal dopamine D(2/3) receptor binding in rats. Addiction Biology. 14: 500-2. PMID 19650815 DOI: 10.1111/J.1369-1600.2009.00168.X  0.656
2009 van de Giessen E, de Win MM, Tanck MW, van den Brink W, Baas F, Booij J. Striatal dopamine transporter availability associated with polymorphisms in the dopamine transporter gene SLC6A3. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 50: 45-52. PMID 19091889 DOI: 10.2967/Jnumed.108.053652  0.669
2009 Schilt T, Goudriaan AE, Koeter MW, van den Brink W, Schmand B. Decision making as a predictor of first ecstasy use: a prospective study. Psychopharmacology. 203: 519-27. PMID 19020868 DOI: 10.1007/S00213-008-1398-Y  0.657
2009 de Ruiter MB, Veltman DJ, Goudriaan AE, Oosterlaan J, Sjoerds Z, van den Brink W. Response perseveration and ventral prefrontal sensitivity to reward and punishment in male problem gamblers and smokers. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 1027-38. PMID 18830241 DOI: 10.1038/Npp.2008.175  0.798
2009 Zijlstra F, Veltman DJ, Booij J, van den Brink W, Franken IH. Neurobiological substrates of cue-elicited craving and anhedonia in recently abstinent opioid-dependent males. Drug and Alcohol Dependence. 99: 183-92. PMID 18823721 DOI: 10.1016/J.Drugalcdep.2008.07.012  0.679
2008 de Win MM, Jager G, Booij J, Reneman L, Schilt T, Lavini C, Olabarriaga SD, den Heeten GJ, van den Brink W. Sustained effects of ecstasy on the human brain: a prospective neuroimaging study in novel users. Brain : a Journal of Neurology. 131: 2936-45. PMID 18842607 DOI: 10.1093/Brain/Awn255  0.625
2008 de Win MM, Jager G, Booij J, Reneman L, Schilt T, Lavini C, Olabarriaga SD, Ramsey NF, Heeten GJ, van den Brink W. Neurotoxic effects of ecstasy on the thalamus. The British Journal of Psychiatry : the Journal of Mental Science. 193: 289-96. PMID 18827290 DOI: 10.1192/Bjp.Bp.106.035089  0.613
2008 Zijlstra F, Booij J, van den Brink W, Franken IH. Striatal dopamine D2 receptor binding and dopamine release during cue-elicited craving in recently abstinent opiate-dependent males. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 18: 262-70. PMID 18077142 DOI: 10.1016/J.Euroneuro.2007.11.002  0.456
2008 Goudriaan AE, Oosterlaan J, De Beurs E, Van Den Brink W. The role of self-reported impulsivity and reward sensitivity versus neurocognitive measures of disinhibition and decision-making in the prediction of relapse in pathological gamblers. Psychological Medicine. 38: 41-50. PMID 17498322 DOI: 10.1017/S0033291707000694  0.674
2007 de Win MM, Reneman L, Jager G, Vlieger EJ, Olabarriaga SD, Lavini C, Bisschops I, Majoie CB, Booij J, den Heeten GJ, van den Brink W. A prospective cohort study on sustained effects of low-dose ecstasy use on the brain in new ecstasy users. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 32: 458-70. PMID 17077812 DOI: 10.1038/Sj.Npp.1301225  0.644
2006 Reneman L, Schilt T, de Win MM, Booij J, Schmand B, van den Brink W, Bakker O. Memory function and serotonin transporter promoter gene polymorphism in ecstasy (MDMA) users. Journal of Psychopharmacology (Oxford, England). 20: 389-99. PMID 16574713 DOI: 10.1177/0269881106063266  0.614
2006 Goudriaan AE, Oosterlaan J, de Beurs E, van den Brink W. Psychophysiological determinants and concomitants of deficient decision making in pathological gamblers. Drug and Alcohol Dependence. 84: 231-9. PMID 16574343 DOI: 10.1016/J.Drugalcdep.2006.02.007  0.658
2006 Goudriaan AE, Oosterlaan J, de Beurs E, van den Brink W. Neurocognitive functions in pathological gambling: a comparison with alcohol dependence, Tourette syndrome and normal controls. Addiction (Abingdon, England). 101: 534-47. PMID 16548933 DOI: 10.1111/J.1360-0443.2006.01380.X  0.701
2006 de Win MM, Schilt T, Reneman L, Vervaeke H, Jager G, Dijkink S, Booij J, van den Brink W. Ecstasy use and self-reported depression, impulsivity, and sensation seeking: a prospective cohort study. Journal of Psychopharmacology (Oxford, England). 20: 226-35. PMID 16510480 DOI: 10.1177/0269881106063275  0.616
2006 Reneman L, de Win MM, van den Brink W, Booij J, den Heeten GJ. Neuroimaging findings with MDMA/ecstasy: technical aspects, conceptual issues and future prospects. Journal of Psychopharmacology (Oxford, England). 20: 164-75. PMID 16510475 DOI: 10.1177/0269881106061515  0.614
2005 De Win MM, Jager G, Vervaeke HK, Schilt T, Reneman L, Booij J, Verhulst FC, Den Heeten GJ, Ramsey NF, Korf DJ, Van den Brink W. The Netherlands XTC Toxicity (NeXT) study: objectives and methods of a study investigating causality, course, and clinical relevance. International Journal of Methods in Psychiatric Research. 14: 167-85. PMID 16395871 DOI: 10.1002/Mpr.6  0.634
2005 Franken IH, Booij J, van den Brink W. The role of dopamine in human addiction: from reward to motivated attention. European Journal of Pharmacology. 526: 199-206. PMID 16256105 DOI: 10.1016/J.Ejphar.2005.09.025  0.445
2005 Goudriaan AE, Oosterlaan J, de Beurs E, van den Brink W. Decision making in pathological gambling: a comparison between pathological gamblers, alcohol dependents, persons with Tourette syndrome, and normal controls. Brain Research. Cognitive Brain Research. 23: 137-51. PMID 15795140 DOI: 10.1016/J.Cogbrainres.2005.01.017  0.663
2005 de Win MM, Habraken JB, Reneman L, van den Brink W, den Heeten GJ, Booij J. Validation of [(123)I]beta-CIT SPECT to assess serotonin transporters in vivo in humans: a double-blind, placebo-controlled, crossover study with the selective serotonin reuptake inhibitor citalopram. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 996-1005. PMID 15770240 DOI: 10.1038/Sj.Npp.1300683  0.592
2004 Goudriaan AE, Oosterlaan J, de Beurs E, Van den Brink W. Pathological gambling: a comprehensive review of biobehavioral findings. Neuroscience and Biobehavioral Reviews. 28: 123-41. PMID 15172761 DOI: 10.1016/J.Neubiorev.2004.03.001  0.679
2004 de Win MM, Reneman L, Reitsma JB, den Heeten GJ, Booij J, van den Brink W. Mood disorders and serotonin transporter density in ecstasy users--the influence of long-term abstention, dose, and gender. Psychopharmacology. 173: 376-82. PMID 14726997 DOI: 10.1007/S00213-003-1723-4  0.623
2002 Reneman L, Booij J, Lavalaye J, de Bruin K, Reitsma JB, Gunning B, den Heeten GJ, van Den Brink W. Use of amphetamine by recreational users of ecstasy (MDMA) is associated with reduced striatal dopamine transporter densities: a [123I]beta-CIT SPECT study--preliminary report. Psychopharmacology. 159: 335-40. PMID 11862367 DOI: 10.1007/S00213-001-0930-0  0.624
2001 Reneman L, Booij J, Majoie CB, Van Den Brink W, Den Heeten GJ. Investigating the potential neurotoxicity of Ecstasy (MDMA): an imaging approach. Human Psychopharmacology. 16: 579-588. PMID 12404537 DOI: 10.1002/Hup.347  0.615
2001 Reneman L, Booij J, de Bruin K, Reitsma JB, de Wolff FA, Gunning WB, den Heeten GJ, van den Brink W. Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons. Lancet. 358: 1864-9. PMID 11741626 DOI: 10.1016/S0140-6736(01)06888-X  0.612
2001 Reneman L, Lavalaye J, Schmand B, de Wolff FA, van den Brink W, den Heeten GJ, Booij J. Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy"): preliminary findings. Archives of General Psychiatry. 58: 901-6. PMID 11576026 DOI: 10.1001/Archpsyc.58.10.901  0.598
2000 Reneman L, Booij J, Schmand B, van den Brink W, Gunning B. Memory disturbances in "Ecstasy" users are correlated with an altered brain serotonin neurotransmission. Psychopharmacology. 148: 322-4. PMID 10755746 DOI: 10.1007/S002130050057  0.603
1994 Ormel J, van den Brink W, van der Meer K, Jenner J, Giel R. [Prevalence, indication and course of depression in family practice]. Nederlands Tijdschrift Voor Geneeskunde. 138: 123-6. PMID 8295637  0.453
1993 Ormel J, Von Korff M, Van den Brink W, Katon W, Brilman E, Oldehinkel T. Depression, anxiety, and social disability show synchrony of change in primary care patients. American Journal of Public Health. 83: 385-90. PMID 8438977 DOI: 10.2105/Ajph.83.3.385  0.758
1992 Wiznitzer M, Verhulst FC, van den Brink W, Koeter M, van der Ende J, Giel R, Koot HM. Detecting psychopathology in young adults: the Young Adult Self Report, the General Health Questionnaire and the Symptom Checklist as screening instruments. Acta Psychiatrica Scandinavica. 86: 32-7. PMID 1414396 DOI: 10.1111/J.1600-0447.1992.Tb03221.X  0.47
1990 Ormel J, Van Den Brink W, Koeter MW, Giel R, Van Der Meer K, Van De Willige G, Wilmink FW. Recognition, management and outcome of psychological disorders in primary care: a naturalistic follow-up study. Psychological Medicine. 20: 909-23. PMID 2284397  0.504
1989 van den Brink W, Koeter MW, Ormel J, Dijkstra W, Giel R, Slooff CJ, Wohlfarth TD. Psychiatric diagnosis in an outpatient population. A comparative study of PSE-Catego and DSM-III. Archives of General Psychiatry. 46: 369-72. PMID 2930333 DOI: 10.1001/archpsyc.1989.01810040075011  0.502
1989 Ormel J, Koeter MW, van den Brink W, Giel R. Concurrent validity of GHQ-28 and PSE as measures of change. Psychological Medicine. 19: 1007-13. PMID 2594877  0.478
Show low-probability matches.